内生
氨基氧乙酸
胱硫醚β合酶
生物
活性氧
鼻咽癌
激酶
p38丝裂原活化蛋白激酶
硫转移酶
生物化学
生长抑制
细胞凋亡
蛋白激酶A
酶
癌症研究
内科学
医学
半胱氨酸
放射治疗
作者
Dayong Wang,Jing Zhang,Haixia Li,Yanxia Zhang,Mi‐Rong Jing,Chunbo Cai,Di Wang,Hui‐Wen Qi,Yizhen Wang,Hao‐Jie Chen,Tao Li,Yuankun Zhai,Xin‐Ying Ji,Dongdong Wu
摘要
Hydrogen sulfide (H2 S) has been widely recognized as one of gasotransmitters. Endogenous H2 S plays a crucial role in the progression of cancer. However, the effect of endogenous H2 S on the development of nasopharyngeal carcinoma (NPC) is still unknown. In this study, aminooxyacetic acid (AOAA, an inhibitor of cystathionine-β-synthase), dl-propargylglycine (PAG, an inhibitor of cystathionine-γ-lyase), and l-aspartic acid (l-Asp, an inhibitor of 3-mercaptopyruvate sulfurtransferase) were adopted to detect the role of endogenous H2 S in NPC growth. The results indicated that the combine (PAG + AOAA + l-Asp) group had higher inhibitory effect on the growth of NPC cells than the PAG, AOAA, and l-Asp groups. There were similar trends in the levels of apoptosis and reactive oxygen species (ROS). In addition, the combine group exhibited lower levels of phospho (p)-extracellular signal-regulated protein kinase but higher expressions of p-p38 and p-c-Jun N-terminal kinase than those in the AOAA, PAG, and l-Asp groups. Furthermore, the combine group exerted more potent inhibitory effect on NPC xenograft tumor growth without obvious toxicity. In summary, suppression of endogenous H2 S generation could dramatically inhibit NPC growth via the ROS/mitogen-activated protein kinase pathway. Endogenous H2 S may be a novel therapeutic target in human NPC cells. Effective inhibitors for H2 S-producing enzymes could be designed and developed for NPC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI